Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 May 21;50(8):750–751. [Article in French] doi: 10.1016/j.medmal.2020.05.004

Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk?

R Amarsy a, Gr Pean de Ponfilly b, Ha Benmansour b, H Jacquier b, Ee Cambau b, B Mégarbane c,*
PMCID: PMC7241335  PMID: 32446986

As coronavirus disease 2019 (COVID-19) patient management requires personal protective equipment (PPE) and rigorous environment cleansing and disinfection, strengthened hospital infection control was expected.

Surprisingly, between mid-February and mid-April 2020, five patients including four out of the 95 COVID-19 patients managed in our intensive care unit (ICU) presented blood and respiratory specimen cultures positive for Serratia marcescens, resistant to amoxicillin, amoxiclav, 1st and 2nd generation cephalosporins (inducible AmpC β-lactamase) and with low-level resistance to amikacin (chromosome-borne aac(6’)-Ic). Isolates were clonal based on whole genome sequencing using Illumina™ procedures. Noteworthy, S. marcescens, a saprophytic environmental Enterobacteriaceae transitory found in human microbiota [1], was commonly implicated in nosocomial infections, especially in neonatal ICUs [2].

After the Infection Prevention and Control Team (IPCT) investigation, an environmental reservoir was suspected as the five patients stayed for at least one day in the same double room (Fig. 1 ). The source patient had been admitted to this room for septic shock due to community-acquired S. marcescens infection from his dialysis catheter, a few days before the COVID-19 outbreak started. Thereafter, S. marcescens acquisition by the COVID-19 patients was likely promoted from the environment due to invasive procedures, high antimicrobial selective pressure and immunomodulatory therapy administration [1], [2], [3]. Additionally, difficulties in applying optimal bio-cleaning procedures during the COVID-19 outbreak may have contributed to facilitating the bacterial reservoir [3]. Transmission between caregivers and patients was facilitated by increased patient density and severity, enhanced workload, and reduced space (e.g., two mechanically ventilated patients managed in rooms routinely dedicated to single patients).

Fig. 1.

Fig. 1

Serratia marcescens outbreak in an adult intensive care unit during the COVID-19 pandemic. Five patients including the non-COVID-19 source patient and four COVID-19 patients stayed for at least one day in the same room (room 115) with a suspected environmental reservoir. The very specific conditions related to patient care during the COVID-19 pandemic facilitated bacterial acquisition and cross-transmission between patients.

Due to the severity of COVID-19 pneumonia, our patients extensively received cefotaxime (82%) to treat a possible bacterial coinfection. They also extensively received azithromycin (93%) as empirical antibiotic treatment in addition to its alleged antiviral and immunomodulatory properties, especially combined with hydroxychloroquine [4]. However, despite these almost systematic antibiotic prescriptions in our COVID-19 patients, we suspected an additional condition that had promoted the S. marcescens outbreak, by contrast to the multidrug-resistant bacteria outbreaks usually attributed to the density of antimicrobial prescriptions in the ICU.

In our ICU, PPE included FFP2 masks, long-sleeved disposable gowns, aprons, goggles, and gloves, as recommended [5]. Caregivers were encouraged to wear gloves during patient care if contact with blood or other body fluids could be reasonably anticipated. They were advised to systematically carry out hand hygiene with alcohol-based hand rub after removing gloves. However, inappropriate excessive glove use, especially in additional staff not trained to manage ICU patients, resulted in poor compliance with hand hygiene, as reported [6]. Unexpectedly, strengthening PPE combined to the fear of self-contamination by SARS-CoV-2 pushed caregivers to wear gloves systematically, even when not required, as soon as entering the patient room. The IPCT observed that several caregivers did not change their gloves between the cares of two patients. This malpractice likely contributed to the room contamination and S. marcescens cross-transmission between patients. Interestingly, cross-transmission due to continuous glove and gown wearing had been responsible for increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern during an outbreak of severe acute respiratory syndrome in a Hong Kong ICU [7].

Here, once the S. marcescens epidemic was identified, intensive bio-cleaning of the room was performed and recommendations to improve hand hygiene were provided to caregivers. No further cases occurred.

During the COVID-19 outbreak, implementation of additional infection control procedures was expected to be associated with a decrease in healthcare-associated infections. Our experience suggests that extra procedures could, by contrast, lead to counterproductive effects if not adequately applied.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments.

Funding

None.

Disclosure of interest

The authors declare that they have no competing interest.

References

  • 1.Mahlen S.D. Serratia infections: from military experiments to current practice. Clin Microbiol Rev. 2011;24:755–791. doi: 10.1128/CMR.00017-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cristina M.L., Sartini M., Spagnolo A.M. Serratia marcescens Infections in Neonatal Intensive Care Units (NICUs) Int J Environ Res Public Health. 2019;16:610. doi: 10.3390/ijerph16040610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.O’Connell N.H., Humphreys H. Intensive care unit design and environmental factors in the acquisition of infection. J Hosp Infect. 2000;45:255–262. doi: 10.1053/jhin.2000.0768. [DOI] [PubMed] [Google Scholar]
  • 4.Mégarbane B., Scherrmann J.M. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? J Clin Pharmacol. 2020 doi: 10.1002/jcph.1646. [in press] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.ECDC. Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19. ECDC technical support 2020 (February 2020). https://www.ecdc.europa.eu/en/publications-data/guidance-wearing-and-removing-personal-protective-equipment-healthcare-settings.(accessed May 07, 2020).
  • 6.Fuller C., Savage J., Besser S., et al. The dirty hand in the latex glove”: a study of hand hygiene compliance when gloves are worn. Infect Control Hosp Epidemiol. 2011;32:1194–1199. doi: 10.1086/662619. [DOI] [PubMed] [Google Scholar]
  • 7.Yap F.H., Gomersall C.D., Fung K.S., et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004;39:511–516. doi: 10.1086/422641. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medecine et Maladies Infectieuses are provided here courtesy of Elsevier

RESOURCES